Valneva SE is a vaccine company focused on developing life-saving vaccines... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
VALN is expected to report earnings to fall 49.42% to -21 cents per share on August 13
Q2'26
Est.
$-0.21
Q1'26
Missed
by $0.24
Q4'25
Missed
by $0.32
Q3'25
Missed
by $0.17
Q2'25
Beat
by $0.22
The last earnings report on May 13 showed earnings per share of -42 cents, missing the estimate of -17 cents. With 27.49K shares outstanding, the current market capitalization sits at 473.48M.